Efficacy of Darifenacin and Physiotherapy for the Treatment of Overactive Bladder in Women
Information source: Universidad de Valparaiso
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Overactive Bladder
Intervention: Darifenacin (Drug); Physiotherapy (Procedure)
Phase: Phase 3
Status: Recruiting
Sponsored by: Universidad de Valparaiso Official(s) and/or principal investigator(s):
Melissa Cifuentes, M.D., Principal Investigator, Affiliation: Senior Urologist
Overall contact:
Melissa Cifuentes, M.D., Phone: 85023219, Ext: +56 9, Email: melissacifuentes@yahoo.com
Summary
Overactive bladder is a common problem among adult women. Darifenacin is an antimuscarinic
drug that is frequently used as part of the management of the condition. However, current
evidence backing its use is limited. This study aims to address Darifenacin's effectiveness
in adjunct to physiotherapy in treating symptoms due to overactive bladder.
Clinical Details
Official title: Efficacy of Darifenacin and Physiotherapy for the Treatment of Overactive Bladder in Women
Study design: Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment
Primary outcome: Quality of Life
Secondary outcome: Overactive Bladder SymptomsAdverse Events
Eligibility
Minimum age: 16 Years.
Maximum age: N/A.
Gender(s): Female.
Criteria:
Inclusion Criteria:
- Patients with overactive bladder as diagnosed and confirmed by a urologist.
- Able to answer the ICIC, King's Health Questionnaire and Overactive Bladder
Questionnaire.
- Able and willing to receive urodynamic studies.
Exclusion Criteria:
- History of pelvic radiotherapy.
- Recent pelvic surgery (<1 year).
- History of anti-incontinence surgery.
- Pregnancy.
Locations and Contacts
Melissa Cifuentes, M.D., Phone: 85023219, Ext: +56 9, Email: melissacifuentes@yahoo.com
Hospital Carlos Van Buren, Valparaiso 2341131, Chile; Recruiting
Juan Pablo Loyola, M.D., Phone: 89322457, Ext: +56 9, Email: juanpablo.loyola.m@gmail.com
Juan Pablo Loyola, M.D., Sub-Investigator
Melissa Cifuentes, M.D., Principal Investigator
Luis Vallejo, M.D., Principal Investigator
Karin Jerez, Physiotherapist, Sub-Investigator
Felipe Martinez, M.D; M.Sc., Sub-Investigator
Additional Information
Starting date: May 2014
Last updated: May 19, 2015
|
